News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Fred R. Hirsch: Great opening of Lung SPORE meeting
Photo from Fred R. Hirsch/X
Jun 14, 2024, 03:39

Fred R. Hirsch: Great opening of Lung SPORE meeting

Fred R. Hirsch, Director at the Center for Thoracic Oncology at Mount Sinai Hospital, shared on X:

“Great opening of Lung SPORE meeting celebrating 20 years of EGFR mutation detection! Proud to be a part of the EGFR history and see the progress in the lung cancer therapy this story has exemplified!”

Source: Fred R. Hirsch/X
cancer Center for Thoracic Oncology EGFR Fred R. Hirsch lung cancer therapy Lung SPORE Mount Sinai Hospital OncoDaily Oncology
Special Coverage
Insight
Jul 5, 2025, 17:07
Evandro de Azambuja: Diversity in Clinical Trials
Positive
Jul 5, 2025, 16:54
Beatrice Okumu: Marking the Successful Launch of 11 City Cancer Challenge Projects in Nairobi
Career
Jul 5, 2025, 16:41
Aleix Prat: Marta Garcia de Herreros is the Winner of the IV Predoctoral Fellowship of the UB Chair of Innovation in Precision Oncology
Blog
Jul 5, 2025, 16:37
Sarah Sammons: A Huge Step Backwards For Cancer Patients
Blog
Jul 5, 2025, 16:32
Aakash Desai: 50 Years of Progress in NSCLC
Science
Jul 5, 2025, 16:24
Udhayvir Grewal: Key Challenges With First-Generation Agents and What’s Ahead for MUC1
Oncolibrary
Jul 5, 2025, 16:18
Thyroid Cancer Cure Rate: What Patients Should Know in 2025
Blog
Jul 5, 2025, 16:17
Razelle Kurzrock: An Abundance of Riches
Insight
Jul 5, 2025, 16:06
Goutham Sunny: VISION Trial and Beyond
Societies
Jul 5, 2025, 15:57
Radiotherapy in Neuroblastoma in the Educational Lectures on Paediatric Radiation Oncology Series - SIOP
Drugs
Jul 5, 2025, 15:54
Tafasitamab-cxix (Monjuvi): What Patients Need to Know About-2025 Updates
Science
Jul 5, 2025, 15:31
Naveen Pemmaraju: Management of BPDCN in the Setting of Severe Co-Morbidities